CLINICAL TRIALS PROFILE FOR RAYALDEE
✉ Email this page to a colleague
All Clinical Trials for RAYALDEE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT04551911 ↗ | Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19 | Completed | OPKO Health, Inc. | Phase 2 | 2020-10-26 | This is a phase 2, single or multi-center, randomized, double-blind placebo-controlled study to evaluate the safety and efficacy of Rayaldee (CTAP101 Capsules) to treat adult subjects with mild to moderate COVID-19 who test positive for SARS-CoV-2 via nasopharynx swab and subsequent reverse transcription polymerase chain reaction (RT-PCR). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for RAYALDEE
Condition Name
Clinical Trial Locations for RAYALDEE
Trials by Country
Clinical Trial Progress for RAYALDEE
Clinical Trial Phase
Clinical Trial Sponsors for RAYALDEE
Sponsor Name